339 related articles for article (PubMed ID: 11334834)
41. Q-T peak dispersion in congenital long QT syndrome: possible marker of mutation of HERG.
Inoue M; Shimizu M; Ino H; Yamaguchi M; Terai H; Hayashi K; Kiyama M; Sakata K; Hayashi T; Mabuchi H
Circ J; 2003 Jun; 67(6):495-8. PubMed ID: 12808265
[TBL] [Abstract][Full Text] [Related]
42. [T wave abnormalities on Holter monitoring of congenital long QT syndrome: phenotypic marker of a mutation of LQT2 (HERG)].
Lupoglazoff JM; Denjoy I; Berthet M; Hainque B; Vaksmann G; Klug D; Villain E; Lucet V; Guicheney P; Coumel P
Arch Mal Coeur Vaiss; 2001 May; 94(5):470-8. PubMed ID: 11434015
[TBL] [Abstract][Full Text] [Related]
43. High affinity open channel block by dofetilide of HERG expressed in a human cell line.
Snyders DJ; Chaudhary A
Mol Pharmacol; 1996 Jun; 49(6):949-55. PubMed ID: 8649354
[TBL] [Abstract][Full Text] [Related]
44. Variable expression of long QT syndrome among gene carriers from families with five different HERG mutations.
Benhorin J; Moss AJ; Bak M; Zareba W; Kaufman ES; Kerem B; Towbin JA; Priori S; Kass RS; Attali B; Brown AM; Ficker E
Ann Noninvasive Electrocardiol; 2002 Jan; 7(1):40-6. PubMed ID: 11844290
[TBL] [Abstract][Full Text] [Related]
45. A novel mutation (T65P) in the PAS domain of the human potassium channel HERG results in the long QT syndrome by trafficking deficiency.
Paulussen A; Raes A; Matthijs G; Snyders DJ; Cohen N; Aerssens J
J Biol Chem; 2002 Dec; 277(50):48610-6. PubMed ID: 12354768
[TBL] [Abstract][Full Text] [Related]
46. Is restoration of intracellular trafficking clinically feasible in the long QT syndrome?: The example of HERG mutations.
Kaufman ES; Ficker E
J Cardiovasc Electrophysiol; 2003 Mar; 14(3):320-2. PubMed ID: 12716119
[No Abstract] [Full Text] [Related]
47. [Electropharmacological assessment of the risk of drug-induced long-QT syndrome using native cardiac cells and cultured cells expressing HERG channels].
Nakaya H
Nihon Yakurigaku Zasshi; 2003 Jun; 121(6):384-92. PubMed ID: 12835532
[TBL] [Abstract][Full Text] [Related]
48. Characterization of a novel missense mutation in the pore of HERG in a patient with long QT syndrome.
Yoshida H; Horie M; Otani H; Takano M; Tsuji K; Kubota T; Fukunami M; Sasayama S
J Cardiovasc Electrophysiol; 1999 Sep; 10(9):1262-70. PubMed ID: 10517660
[TBL] [Abstract][Full Text] [Related]
49. Screening for mutations and polymorphisms in the genes KCNH2 and KCNE2 encoding the cardiac HERG/MiRP1 ion channel: implications for acquired and congenital long Q-T syndrome.
Larsen LA; Andersen PS; Kanters J; Svendsen IH; Jacobsen JR; Vuust J; Wettrell G; Tranebjaerg L; Bathen J; Christiansen M
Clin Chem; 2001 Aug; 47(8):1390-5. PubMed ID: 11468227
[TBL] [Abstract][Full Text] [Related]
50. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome.
Curran ME; Splawski I; Timothy KW; Vincent GM; Green ED; Keating MT
Cell; 1995 Mar; 80(5):795-803. PubMed ID: 7889573
[TBL] [Abstract][Full Text] [Related]
51. The distinct HERG missense mutation L564P causes long QT syndrome in one French Canadian family.
St-Pierre J; Roy N; Blier L; Plante E; Cote JM; Gilbert M; Chahine M
Can J Cardiol; 2000 Mar; 16(3):307-12. PubMed ID: 10744792
[TBL] [Abstract][Full Text] [Related]
52. [18-year old patient with anti-epileptic therapy and sudden cardiac death].
Witzenbichler B; Schulze-Bahr E; Haverkamp W; Breithardt G; Sticherling C; Behrens S; Schultheiss HP
Z Kardiol; 2003 Sep; 92(9):747-53. PubMed ID: 14508592
[TBL] [Abstract][Full Text] [Related]
53. [Evaluation of pro-arrhythmic risk of drugs due to QT interval prolongation by the HERG expression system].
Chachin M; Kurachi Y
Nihon Yakurigaku Zasshi; 2002 Jun; 119(6):345-51. PubMed ID: 12089906
[TBL] [Abstract][Full Text] [Related]
54. The anti-malarial drug halofantrine and its metabolite N-desbutylhalofantrine block HERG potassium channels.
Mbai M; Rajamani S; January CT
Cardiovasc Res; 2002 Sep; 55(4):799-805. PubMed ID: 12176129
[TBL] [Abstract][Full Text] [Related]
55. Identification of a COOH-terminal segment involved in maturation and stability of human ether-a-go-go-related gene potassium channels.
Akhavan A; Atanasiu R; Shrier A
J Biol Chem; 2003 Oct; 278(41):40105-12. PubMed ID: 12885765
[TBL] [Abstract][Full Text] [Related]
56. The variant hERG/R148W associated with LQTS is a mutation that reduces current density on co-expression with the WT.
Mechakra A; Vincent Y; Chevalier P; Millat G; Ficker E; Jastrzebski M; Poulin H; Pouliot V; Chahine M; Christé G
Gene; 2014 Feb; 536(2):348-56. PubMed ID: 24334129
[TBL] [Abstract][Full Text] [Related]
57. Defective human Ether-à-go-go-related gene trafficking linked to an endoplasmic reticulum retention signal in the C terminus.
Kupershmidt S; Yang T; Chanthaphaychith S; Wang Z; Towbin JA; Roden DM
J Biol Chem; 2002 Jul; 277(30):27442-8. PubMed ID: 12021266
[TBL] [Abstract][Full Text] [Related]
58. KCNQ1 and KCNH2 mutations associated with long QT syndrome in a Chinese population.
Liu W; Yang J; Hu D; Kang C; Li C; Zhang S; Li P; Chen Z; Qin X; Ying K; Li Y; Li Y; Li Z; Cheng X; Li L; Qi Y; Chen S; Wang Q
Hum Mutat; 2002 Dec; 20(6):475-6. PubMed ID: 12442276
[TBL] [Abstract][Full Text] [Related]
59. Congenital and acquired long QT syndrome.
Camm AJ; Janse MJ; Roden DM; Rosen MR; Cinca J; Cobbe SM
Eur Heart J; 2000 Aug; 21(15):1232-7. PubMed ID: 10924312
[No Abstract] [Full Text] [Related]
60. A common polymorphism in KCNH2 (HERG) hastens cardiac repolarization.
Bezzina CR; Verkerk AO; Busjahn A; Jeron A; Erdmann J; Koopmann TT; Bhuiyan ZA; Wilders R; Mannens MM; Tan HL; Luft FC; Schunkert H; Wilde AA
Cardiovasc Res; 2003 Jul; 59(1):27-36. PubMed ID: 12829173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
